UNITED STATES SECURITIES AND EXCHANGE COMMISSION

                      WASHINGTON, DC  20549


                            FORM 10-Q

   (MARK ONE) QUARTERLY REPORT / X / OR TRANSITION REPORT /  /
               PURSUANT TO SECTION 13 OR 15(d) OF
               THE SECURITIES EXCHANGE ACT OF 1934



For the quarter ended
October 31, 2000                       Commission File No. 1-5865



                     GERBER SCIENTIFIC, INC.
                ---------------------------------
                   (Exact name of Registrant as
                    specified in its charter)



           CONNECTICUT                             06-0640743
 -------------------------------              ---------------------
 (State or other jurisdiction of                  (IRS Employer
  incorporation or organization)               Identification No.)


 83 Gerber Road West, South Windsor, Connecticut       06074
------------------------------------------------- ---------------
    (Address of principal executive offices)         (Zip Code)



Registrant's Telephone Number, including area      (860) 644-1551
code                                              ---------------


Indicate  by check mark whether the registrant (1) has filed  all
reports  required  to be filed by Section  13  or  15(d)  of  the
Securities  Exchange Act of 1934 during the preceding  12  months
(or  for such shorter period that the registrant was required  to
file  such  reports)  and  (2) has been subject  to  such  filing
requirements for the past 90 days.


                     Yes  / X / .   No /    /.

At  October  31, 2000, 22,013,067 shares of common stock  of  the
Registrant were outstanding.

<PAGE 1>

                     GERBER SCIENTIFIC, INC.
                        AND SUBSIDIARIES
            CONTENTS OF QUARTERLY REPORT ON FORM 10-Q

                 Quarter Ended October 31, 2000


                                                             PAGE



Part I - Financial Information

  Item 1. Consolidated Financial Statements:

           Statements of Earnings for the three months
           ended October 31, 2000 and 1999                   2

           Statements of Earnings for the six months
           ended October 31, 2000 and 1999                   3

           Balance Sheets at October 31, 2000 and
           April 30, 2000                                  4-5

           Statements of Cash Flows for the six months
           ended October 31, 2000 and 1999                   6

           Notes to Financial Statements                     7

           Independent Accountants' Report                  12

  Item 2. Management's Discussion and Analysis of
           Financial Condition and Results of Operations    13

  Item 3. Quantitative and Qualitative Disclosures
          About Market Risk                                 18


Part II - Other Information

  Item 5. Other Information                                 19

  Item 6.  Exhibits and Reports on Form 8-K                 20


Signature                                                   21

Exhibit Index                                               22

<PAGE 2>

PART I - FINANCIAL INFORMATION

ITEM 1. CONSOLIDATED FINANCIAL STATEMENTS

            GERBER SCIENTIFIC, INC. AND SUBSIDIARIES
               CONSOLIDATED STATEMENTS OF EARNINGS

--------------------------------------------------------------
                                          Three Months Ended
In thousands (except per share amounts)       October 31,
--------------------------------------- ----------------------
                                           2000        1999
                                        ---------    ---------
Revenue:

  Product sales                         $130,463     $139,598
  Service                                 12,391       13,255
                                        --------     --------
                                         142,854      152,853
                                        --------     --------

Costs and Expenses:

  Cost of product sales                   82,589       82,412
  Cost of service                          7,940        7,188
  Selling, general and administrative     35,846       38,442
  Research and development expenses        7,515        8,304
  Goodwill amortization                    2,235        2,114
                                        --------     --------
                                         136,125      138,460
                                        --------     --------

Operating income                           6,729       14,393

Other income (expense)                      (434)         744
Interest expense                          (3,350)      (2,407)
                                        --------     --------

Earnings before income taxes               2,945       12,730

Provision for income taxes                 1,100        4,400
                                        --------     --------
Net earnings                            $  1,845     $  8,330
                                        ========     ========
Per share of common stock:
  Basic                                 $    .08     $    .38
  Diluted                               $    .08     $    .37

  Dividends                             $    .08     $    .08

Average shares outstanding:
  Basic                                   22,009       22,175
  Diluted                                 22,009       22,474

                     See Accompanying Notes

<PAGE 3>

            GERBER SCIENTIFIC, INC. AND SUBSIDIARIES
               CONSOLIDATED STATEMENTS OF EARNINGS

--------------------------------------------------------------
                                            Six Months Ended
In thousands (except per share amounts)       October 31,
--------------------------------------- ----------------------
                                           2000        1999
                                        ---------    ---------
Revenue:

  Product sales                         $256,421     $265,454
  Service                                 24,823       26,875
                                        --------     --------
                                         281,244      292,329
                                        --------     --------

Costs and Expenses:

  Cost of product sales                  163,692      155,033
  Cost of service                         16,338       14,493
  Selling, general and administrative     71,769       73,534
  Research and development expenses       15,270       16,902
  Goodwill amortization                    4,476        4,250
  Special charge                           4,419           --
                                        --------     --------
                                         275,964      264,212
                                        --------     --------

Operating income                           5,280       28,117

Other income                                 106        1,137
Interest expense                          (6,636)      (4,871)
                                        --------     --------

Earnings (loss) before income taxes       (1,250)      24,383

Provision (benefit) for income taxes        (400)       8,500
                                        --------     --------
Net earnings (loss)                     $   (850)    $ 15,883
                                        ========     ========
Per share of common stock:
  Basic                                 $   (.04)    $    .72
  Diluted                               $   (.04)    $    .71

  Dividends                             $    .16     $    .16

Average shares outstanding:
  Basic                                   22,003       22,147
  Diluted                                 22,003       22,463

                     See Accompanying Notes

<PAGE 4-5>

             GERBER SCIENTIFIC, INC. AND SUBSIDIARIES
                   CONSOLIDATED BALANCE SHEETS


---------------------------------------------------------------
                                         October 31,  April 30,
In thousands                               2000         2000
--------------------------------------   ----------  ----------
Assets
Current Assets:
 Cash and short-term cash investments     $ 18,073     $ 22,954
 Accounts receivable                       102,907      121,494
 Inventories                                85,940       86,472
 Prepaid expenses                           20,459       21,042
 Net assets held for sale                   30,305           --
                                          --------     --------
                                           257,684      251,962
                                          --------     --------
Property, Plant and Equipment              118,321      165,341
 Less accumulated depreciation              52,459       66,121
                                          --------     --------
                                            65,862       99,220
                                          --------     --------
Intangible Assets                          245,270      245,797
 Less accumulated amortization              32,160       27,419
                                          --------     --------
                                           213,110      218,378
                                          --------     --------
Other Assets                                 4,219        3,276
                                          --------     --------
                                          $540,875     $572,836
                                          ========     ========
Liabilities and Shareholders' Equity

Current Liabilities:
 Notes payable                            $     --    $      --
 Accounts payable                           48,268       58,043
 Accrued compensation and benefits          12,836       16,646
 Other accrued liabilities                  26,679       26,689
 Deferred revenue                            8,525        8,436
 Advances on sales contracts                 2,093        2,610
                                          --------     --------
                                            98,401      112,424
                                          --------     --------
Noncurrent Liabilities:
 Deferred income taxes                       8,325        8,608
 Long-term debt                            183,475      194,892
                                          --------     --------
                                           191,800      203,500
                                          --------     --------

Contingencies and Commitments

Shareholders' Equity:
 Preferred stock, no par value;
  authorized 10,000,000 shares; no
  shares issued                                 --           --
 Common stock, $1.00 par value;
  authorized 65,000,000 shares; issued
  22,805,185 and 22,779,651 shares          22,805       22,780
 Paid-in capital                            43,786       43,615
 Retained earnings                         206,382      210,749
 Treasury stock, at cost (792,118
  and 797,444 shares, respectively)        (16,288)     (16,397)
 Unamortized value of restricted stock
  grants                                      (524)        (557)
 Accumulated other comprehensive income
  (loss)                                    (5,487)      (3,278)
                                          --------     --------
                                           250,674      256,912
                                          --------     --------
                                          $540,875     $572,836
                                          ========     ========

                     See Accompanying Notes

<PAGE 6>

            GERBER SCIENTIFIC, INC. AND SUBSIDIARIES
              CONSOLIDATED STATEMENTS OF CASH FLOWS
---------------------------------------------------------------------

                                                  Six Months Ended
In thousands                                         October 31,
--------------------------------------------    ---------------------

                                                  2000         1999
                                               ----------   ---------
Cash Provided by (Used for):
Operating Activities:
  Net earnings (loss)                           $   (850)   $ 15,883
  Adjustments to reconcile net earnings(loss)
   to cash provided by operating activities:
     Depreciation and amortization                13,993      12,359
     Special charge                                4,419          --
     Deferred income taxes                          (283)        722
     Other non-cash items                            265         155
     Changes in operating accounts, net of
      effects of business acquisitions:
      Receivables                                 18,587     (15,024)
      Inventories                                    532     (15,691)
      Prepaid expenses                               583       3,079
      Accounts payable and accrued expenses      (15,266)      2,580
                                                --------    --------
Provided by Operating Activities                  21,980       4,063
                                                --------    --------
Investing Activities:
  Additions to property, plant and equipment      (8,872)    (13,251)
  Business acquisitions                               --      (7,452)
  Intangible and other assets                       (752)       (340)
  Other, net                                      (2,209)       (391)
                                                --------    --------
(Used for) Investing Activities                  (11,833)    (21,434)
                                                --------    --------
Financing Activities:
  Additions of long-term debt                     23,000      30,274
  Repayments of long-term debt                   (34,417)    (16,229)
  Net short-term financing                            --      (1,249)
  Debt issue costs                                  (167)         --
  Proceeds from issuance of stock                     73       1,809
  Dividends on common stock                       (3,517)     (3,539)
                                                --------    --------
Provided by (Used for) Financing Activities      (15,028)     11,066
                                                --------    --------

(Decrease) in Cash and Short-Term
  Cash Investments                                (4,881)     (6,305)

Cash and Short-Term Cash Investments,
  Beginning of Period                             22,954      26,523
                                                --------    --------

Cash and Short-Term Cash Investments,           $ 18,073    $ 20,218
  End of Period                                 ========    ========
                     See Accompanying Notes

<PAGE 7>

            GERBER SCIENTIFIC, INC. AND SUBSIDIARIES
     NOTES TO (UNAUDITED) CONSOLIDATED FINANCIAL STATEMENTS

NOTE 1. Basis of Presentation

The accompanying unaudited consolidated financial statements have
been  prepared  in accordance with generally accepted  accounting
principles  for  interim  financial  statements  and   with   the
instructions  to  Form  10-Q and Article 10  of  Regulation  S-X.
Accordingly,  they  do  not include all of  the  information  and
footnotes  required  by generally accepted accounting  principles
for complete financial statements.  In the opinion of management,
all   adjustments  (consisting  of  normal  recurring   accruals)
considered necessary for a fair presentation have been  included.
Operating  results  for  the three- and six-month  periods  ended
October  31,  2000 are not necessarily indicative of the  results
that may be expected for the year ended April 30, 2001.

For  further  information,  refer to the  consolidated  financial
statements and footnotes thereto included in the Company's Annual
Report on Form 10-K for the year ended April 30, 2000.

NOTE 2. Inventories

The classification of inventories was as follows (in thousands):

                                October 31, 2000  April 30, 2000
                                ----------------  --------------
Raw materials & purchased parts     $55,746            $52,847
Work in process                      30,194             33,625
                                    -------            -------
                                    $85,940            $86,472
                                    =======            =======

NOTE 3. Special Charge and Net Assets Held for Sale

In  June  2000, the Company began implementation of a program  to
reduce the number of employees by approximately 7.5 percent (225-
240   people)  through  early  retirement  incentives,  voluntary
separation   arrangements,   and  involuntary   severance.    The
workforce  reductions  primarily affected  the  Sign  Making  and
Specialty  Graphics and Apparel and Flexible Materials  operating
segments.  The  Company recorded a special charge  in  the  first
quarter  of  2000  that included $1.9 million of  provisions  for
employee  termination benefits (110 employees affected).   As  of
October 31, 2000, 71 of these employees have been terminated  and
approximately $0.8 million, or 40 percent of the accrual for  the
program, had been paid.

The  special  charge  also  included provisions  for  anticipated
losses  on  the sale of facilities amounting to $2.3 million  and
losses  for other impaired assets, principally patents, amounting
to  $0.2 million.  These facilities had a carrying value of  $5.7
million  after the provision and are included in the October  31,

<PAGE 8>

2000  balance  sheet in the caption "Net assets  held  for  sale"
along  with  certain  other facilities that are  the  subject  of
sale/leaseback negotiations.

The  Company determined the impairment loss on the facilities  in
accordance  with Statement of Financial Accounting Standards  No.
121, "Accounting for the Impairment of Long-Lived Assets and  for
Long-Lived  Assets  to be Disposed Of." Under this  standard,  an
impairment is recognized when the future undiscounted cash  flows
from  these  assets are estimated to be insufficient  to  recover
their  related carrying values.  Accordingly, the carrying values
of  these assets were written down to the Company's estimates  of
fair  value.   Actual results from the sale of  these  facilities
could vary from these estimates.

NOTE 4. Segment Information

                         Three Months Ended   Six Months Ended
In thousands                October 31,          October 31,
-----------------------  -----------------   -------------------
                           2000      1999      2000      1999
                         --------  --------   --------  --------
Segment revenue:
 Sign Making &
  Specialty Graphics     $ 70,112  $ 72,993   $138,965  $141,327
 Apparel & Flexible
  Materials                49,615    56,607     96,502   105,472
 Ophthalmic Lens
  Processing               23,127    23,253     45,777    45,530
                         --------  --------   --------  --------
                         $142,854  $152,853   $281,244  $292,329
                         ========  ========   ========  ========
Segment profit:
 Sign Making &
  Specialty Graphics     $  4,404  $  8,782   $  7,259  $ 17,648
 Apparel & Flexible
  Materials                 1,605     6,607      1,458    11,751
 Ophthalmic Lens
  Processing                1,281     1,416      2,121     2,667
                         --------  --------   --------  --------
                         $  7,290  $ 16,805   $ 10,838  $ 32,066
                         ========  ========   ========  ========

A  reconciliation  of  total  segment  profits  to  consolidated
earnings before income taxes follows:

                         Three Months Ended    Six Months Ended
In thousands                 October 31,         October 31,
------------------------ ------------------    ----------------
                           2000       1999      2000      1999
                          --------  --------   -------   -------
Segment profit             $ 7,290  $ 16,805   $10,838  $ 32,066
Corporate expenses and
  special charge, net of
  other income/expense        (995)   (1,668)   (5,452)   (2,812)
                          --------  --------  --------  --------
Earnings before interest
  and taxes                  6,295    15,137     5,386    29,254
Interest expense            (3,350)   (2,407)   (6,636)   (4,871)
                          --------  --------  --------  --------
Earnings (loss) before
  income taxes             $ 2,945  $ 12,730   $(1,250) $ 24,383
                          ========  ========  ========  ========

<PAGE 9-10>

There were no material changes in segment assets, the measure of
segment  profit,  or  differences in the basis  of  segmentation
since the Company's last Annual Report on Form 10-K.

NOTE 5. Comprehensive Income

The Company's total comprehensive income was as follows:

                              Three Months     Six Months Ended
In thousands                Ended October 31,     October 31,
--------------------------  -----------------  ----------------
                              2000     1999     2000      1999
                            -------  -------   -------  -------
Net earnings (loss)         $ 1,845  $ 8,330   $  (850) $15,883
Other comprehensive income
 (loss):
  Foreign currency
   translation adjustments   (2,423)  (1,083)   (2,209)  (1,648)
                            -------   -------  -------  -------
  Total comprehensive
   income (loss)            $  (578) $ 7,247   $(3,059) $14,235
                            =======  =======   =======  =======

NOTE 6. Earnings Per Share

The  following  table  sets forth the computation  of  basic  and
diluted earnings per share for the periods indicated:

                           Three Months Ended        Six Months Ended
                               October 31,              October 31,
                         -----------------------  -----------------------
                            2000        1999          2000        1999
                         ----------  ----------   ----------- -----------
Numerator:
 Net income (loss)        $1,845,000 $ 8,330,000   $(850,000) $15,883,000
                          ========== ===========   ========== ===========
Denominators:
 Denominator for basic
  earnings per share--
  weighted-average
  shares outstanding      22,008,787  22,175,402   22,003,089  22,146,571
 Effect of dilutive
  securities:
  Stock options                   --     298,299           --     316,040
                          ---------- -----------   ---------- -----------
  Denominator for
   diluted earnings
   per share-adjusted
   weighted-average
   shares outstanding     22,008,787  22,473,701   22,003,089  22,462,611
                          ========== ===========   ========== ===========
Basic earnings (loss)
 per share               $       .08 $       .38  $     (.04) $       .72
                         =========== ===========  =========== ===========
Diluted earnings (loss)
 per share               $       .08 $       .37  $     (.04) $       .71
                         =========== ===========  =========== ===========


For  the  quarter  ended October 31, 2000, there  were  no  common  stock
equivalents because the average market price for the Company's stock  was
lower than the exercise price on all outstanding stock options.  For  the
six  months  ended  October 31, 2000, there were 1,497 shares  of  common
stock  equivalents that were not included in the calculation  of  diluted
EPS above because they were antidilutive.


<PAGE 11>

GERBER SCIENTIFIC, INC. AND SUBSIDIARIES


With  respect to the unaudited consolidated financial  statements
of  Gerber Scientific, Inc. and subsidiaries at October 31,  2000
and  for the three- and six-month periods ended October 31,  2000
and 1999, KPMG LLP has made a review (based on procedures adopted
by  the  American Institute of Certified Public Accountants)  and
not  an  audit,  as  set  forth in their  separate  report  dated
November  29,  2000 appearing on page 12.  That report  does  not
express   an   opinion  on  the  interim  unaudited  consolidated
financial  information.   KPMG  LLP  has  not  carried  out   any
significant  or additional audit tests beyond those  which  would
have  been  necessary  if  their report had  not  been  included.
Accordingly,  such  report  is not a "report"  or  "part  of  the
Registration Statement" within the meaning of Sections 7  and  11
of  the  Securities Act of 1933 and the liability  provisions  of
Section 11 of such Act do not apply.

<PAGE 12>


                 INDEPENDENT ACCOUNTANTS' REPORT


To the Board of Directors and Shareholders of
Gerber Scientific, Inc.


We  have made a review of the consolidated statements of earnings
of  Gerber  Scientific, Inc. and subsidiaries for the three-  and
six-month   periods  ended  October  31,  2000  and   1999,   the
consolidated  statements of cash flows for the six-month  periods
ended  October  31,  2000 and 1999, and the consolidated  balance
sheet  as  of  October  31,  2000 in  accordance  with  standards
established  by  the  American  Institute  of  Certified   Public
Accountants.   We  have previously audited,  in  accordance  with
auditing  standards  generally  accepted in the  United States of
America,  and   expressed  our unqualified  opinion dated May 24,
2000 on the consolidated financial statements  for the year ended
April  30,  2000  (not  presented  herein).  The  aforementioned
financial  statements  are the  responsibility  of the Company's
management.

A review of interim financial information consists principally of
applying  analytical  review procedures  to  financial  data  and
making  inquiries  of  persons  responsible  for  financial   and
accounting  matters.  It is substantially less in scope  than  an
examination  in  accordance  with  auditing  standards  generally
accepted in the United States of America, the objective  of which
is the expression of an opinion regarding the financial statements
taken as a whole. Accordingly, we do not express such an opinion.

Based   on   our  review,  we  are  not  aware  of  any  material
modifications   that   should  be  made   to   the   accompanying
consolidated statements of earnings for the three- and  six-month
periods  ended  October  31,  2000  and  1999,  the  consolidated
statements of cash flows for the six-month periods ended  October
31,  2000  and  1999,  or the consolidated balance  sheet  as  of
October  31,  2000  for them to be in conformity  with accounting
principles  generally  accepted  in the United States of America.
Also, in our opinion the information in the accompanying consolidated
balance sheet as  of April 30, 2000 is fairly  presented, in  all
material respects,  in relation to the consolidated balance sheet
from which it has been derived.


/s/ KPMG LLP


Hartford, Connecticut
November 29, 2000


<PAGE 13>

ITEM 2.   MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL
CONDITION AND RESULTS OF OPERATIONS


FINANCIAL CONDITION

The  Company's ratio of current assets to current liabilities was
2.6  to 1 at October 31, 2000 compared with 2.2 to 1 at April 30,
2000.   Net  working  capital  at October  31,  2000  was  $159.3
million,  compared with $139.5 million at April  30,  2000.   The
October 31, 2000 amount included $30.3 million of net assets held
for  sale  that were reclassified from net property,  plant,  and
equipment at April 30, 2000.  The Company plans to sell two  idle
facilities and a separate parcel of land, and enter into sale and
leaseback  transactions  for  three  additional  facilities.  The
Company expects to use the net cash proceeds from asset sales and
sale leaseback transactions to reduce long-term debt.

Adjusting  for the reclassification of assets held for sale,  net
working  capital at October 31, 2000 decreased by  $10.6  million
from  the beginning of the fiscal year.  The decrease was largely
attributable  to lower accounts receivable balances,  which  were
caused  by management's concerted efforts to accelerate  customer
collections.   Lower  sales levels in both the  Sign  Making  and
Specialty  Graphics and Apparel and Flexible Materials  operating
segments also reduced accounts receivable balances.

The  Company's  cash  and investments totaled  $18.1  million  at
October  31, 2000 compared with $23.0 million at the end  of  the
prior  fiscal year.  Operating activities provided $22.0  million
in  cash for the six-month period ended October 31, 2000 compared
with  $4.1 million provided by operating activities for the  same
period  last year.  Operating cash was generated by the add  back
of non-cash charges for depreciation and amortization and the non-
cash  elements of this year's first quarter special  charge,  and
was  supplemented  by  the  lower accounts  receivable  balances.
Lower  accounts  payable  and  accrued  liability  balances,  due
largely to the timing of payments this year, were partial offsets
to cash generation in the first six months.

The  principal non-operating use of cash in the six months  ended
October  31,  2000  was  for additions to  property,  plant,  and
equipment  of  $8.9  million.   The Company  anticipates  capital
expenditures  for the current fiscal year to be in the  range  of
$15.0 - $16.0 million and expects to fund these with cash on hand
and  cash  from  operations.  Cash was also used for  payment  of
dividends of $3.5 million in this year's first six months.

The Company's total long-term debt at October 31, 2000 was $183.5
million,  down from the April 30, 2000 balance of $194.9 million.
The  ratio  of  total debt to EBITDA (earnings  before  interest,
taxes,  depreciation,  and amortization)  has  increased  in  the
current  fiscal year and this has caused interest  rates  on  the
Company's  borrowings under its syndicated bank line to increase.

<PAGE 14>

Net  debt  (total  debt  less cash and  investments)  was  $165.4
million  at October 31, 2000 versus $171.9 million at  April  30,
2000  and  the  ratio  of  net debt to  total  capital  decreased
slightly to 39.8 percent at October 31, 2000 from 40.1 percent at
April 30, 2000.

RESULTS OF OPERATIONS

Combined  sales  and  service revenue for the three-month  period
ended October 31, 2000 decreased $10.0 million (6.5 percent)  and
for  the six-month period ended October 31, 2000 decreased  $11.1
million (3.8 percent) from the prior year comparable periods. The
decreases reflected both lower product sales and service revenue.
Weaker  foreign currency translation rates, especially in Europe,
suppressed product sales revenue approximately $10.9 million  and
$17.6  million in the three- and six-month periods ended  October
31,  2000, respectively. Holding exchange rates constant, product
sales  were  higher in this year's second quarter and  first  six
months  in  the  Sign  Making  and Specialty  Graphics  operating
segment  and in the Ophthalmic Lens Processing operating segment,
but  lower for both periods in the Apparel and Flexible Materials
operating segment. Weaker demand for equipment in North  American
markets   pressured  product  sales  in  each  of  the  Company's
operating  segments.   Foreign currency  effects  on  competitive
pricing in European markets further reduced product sales in  the
Apparel  and  Flexible Materials operating  segment.   Businesses
that  were acquired in the prior year generated $4.2 million  and
$10.4  million  of  incremental sales  in  the  Sign  Making  and
Specialty  Graphics operating segment in the second  quarter  and
first six months of the current year.

Service  revenue  decreased $0.9 million (6.5 percent)  and  $2.1
million  (7.6 percent) in the three- and six-month periods  ended
October  31,  2000, respectively, from the prior year  comparable
periods.   The  decreases occurred primarily in the  Apparel  and
Flexible  materials  operating  segment  and  resulted  from  the
translation  effect on service revenue earned in weaker  European
currencies  and  some loss of service business in North  America.
The  decline  in  North American service is coincident  with  the
continuing migration of the apparel industry to offshore locales.

The  consolidated gross profit margins in this year's three-  and
six-month  periods ended October 31, 2000 were 36.6  percent  and
36.0  percent, respectively, which were significantly lower  than
the  prior  year margins of 41.4 and 42.0 percent.  Gross  profit
margins  on both product sales and service revenue were lower  in
the  current year.  The decreases were the result of a  shift  in
sales  mix  on both a product and geographic basis and  also  the
sales   impact   of  lowered  European  currency  values,   which
compressed  margins and impacted price competitiveness.   From  a
business mix perspective, equipment sales (hardware and software)
slipped  to 41.4 percent and 40.2 percent of the Company's  total
sales  for  the  three- and six-month periods ended  October  31,
2000, compared with 44.3 percent and 42.7 percent of sales in the

<PAGE 15>

prior  year  comparable periods.  Within the equipment  category,
hardware  sales  were higher in the current year while  sales  of
computer  aided  design  systems, software,  and  services  (with
comparatively higher margins) were lower.  On a geographic basis,
an increase in sales in international markets and weakness in the
North   American  equipment  market  had  negative  gross  margin
implications  in the second quarter and first six months  of  the
current   year.  Sales  in  North  America  are  generally   more
profitable  than in international markets where sales go  through
the  Company's independent distribution and agency  network.  The
continued  deterioration of foreign currency  valuations  further
eroded  gross profits from the prior year in the Sign Making  and
Specialty  Graphics and Apparel and Flexible Materials  operating
segments.   This  margin impact resulted from sales  of  products
manufactured with a U.S. dollar cost-base and sold in  Europe  in
weaker local currencies.

The decrease in service gross profit margins in this year's three-
and six-month periods ended October 31, 2000 resulted from improved
classification  of  expenses  as a  result of implementaton of an
enterprise resource planning system.  The new system distinguishes
more clearly between warranty, installation,  and training and the
fulfillment of service contract  obligations. The decrease in this
segment's North American service business noted above also was a
factor in the margin decline.

Selling,  general, and administrative (S,G,&A) expenses decreased
$2.6 million (6.8 percent) in this year's second quarter and $1.8
million  (2.4 percent) in this year's first six months  from  the
prior  year  comparable periods. Contributing to these  decreases
were cost reduction actions taken in this year's first quarter to
reduce  employment  levels,  largely affecting  the  Apparel  and
Flexible   Materials  and  Sign  Making  and  Specialty  Graphics
operating  segments.   Additional expenses  associated  with  the
businesses  acquired last year in the Sign Making  and  Specialty
Graphics  operating  segment  were  a  partial  offset.    As   a
percentage  of sales, S,G,&A expenses were 25.1 percent  in  both
years' second quarters and were 25.5 percent and 25.2 percent  of
sales  for the six-month periods ended October 31, 2000 and 1999,
respectively.

R&D  spending decreased $0.8 million (9.5 percent) in this year's
second  quarter  and $1.6 million (9.7 percent)  in  this  year's
first  six  months.  There were comparatively  higher  levels  of
expenses  related  to new product introductions  in  last  year's
first  half  in each of the Company's operating segments.   As  a
percentage of sales, research and development was 5.3 percent  in
the  second  quarter  and 5.4 percent in  the  first  six  months
compared with 5.4 percent and 5.8 percent, respectively,  in  the
prior year periods.

In this year's first quarter, the Company recorded a $4.4 million
pre-tax special charge that consisted of provisions for severance
of  $1.9 million, provisions for losses on the sale of facilities

<PAGE 16>

of  $2.3  million, and $0.2 million for other asset  impairments.
See  Note  3 on page 7 of this quarterly report on Form 10-Q  for
further discussion of this special charge.

Interest expense increased $0.9 million in the second quarter and
$1.8  million  in  the  first six months  of  the  current  year,
principally  the result of higher interest rates and also  higher
debt  balances.   Substantially all of the  Company's  borrowings
were  against  a  $235  million multi-currency  revolving  credit
facility.  The interest rate on these borrowings is based on  the
London  Interbank Offered Rate (LIBOR) for the relevant  currency
and term plus a margin based on the relationship of the Company's
consolidated  total  debt  to  EBITDA  over  the  trailing   four
quarters.   The  lower  EBITDA realized by the  Company  in  last
year's fourth quarter and this year's first half has caused  this
debt to EBITDA relationship to rise, and accordingly the interest
margin  over LIBOR to rise.  As a result of this higher  debt  to
EBITDA  relationship,  the Company was  required  to  renegotiate
certain  debt  covenants in its syndicated  bank  agreement,  the
effect  of  which has increased the interest margin  over  LIBOR.
Accordingly,  management  believes  that  interest  expense  will
remain  at  a  higher  level until the full impact  of  its  cost
reduction,  working capital improvement, and asset sale  programs
are implemented and the debt to EBITDA relationship improves.

The  benefit rate for income taxes was 32.0 percent for the  six-
month  period ended October 31, 2000.  This compared with  a  tax
provision  rate  of  34.9 percent in the  comparable  prior  year
period and a 33.6 percent provision rate for the full prior year.
The  components  of  the  tax rates in the  two  years  were  not
substantially  different;  the  comparability  of  the  resulting
percentages was affected more by the relatively small size of the
pre-tax loss in this year's six-month period.

As  a  result of the above, net earnings decreased in this year's
second quarter to $1.8 million or $.08 diluted earnings per share
from  $8.3  million or $.37 diluted earnings per  share  in  last
year's second quarter.  For the first six months, net earnings in
this year's first half were $2.0 million or $.09 diluted earnings
per  share, before the special charge of $2.8 million, net  after
taxes, or $.13 per diluted share.  A net loss of $0.8 million  or
$.04 per share was realized in this year's first six months after
the  special  charge.  Net earnings were $15.9  million  or  $.71
diluted earnings per share in last year's first half.

NEW ACCOUNTING PRONOUNCEMENT

In  June  1998, the Financial Accounting Standards  Board  (FASB)
issued  Statement  of  Financial Accounting  Standards  No.  133,
"Accounting  for  Derivative Instruments and Hedging  Activities"
(SFAS 133) which, as amended, is currently effective May 1, 2001,
for  the Company.  The timing of adoption and the effect of  SFAS
133  on the Company's financial position or results of operations
have not yet been determined.

<PAGE 17>

FORWARD-LOOKING STATEMENTS

This report on Form 10-Q contains statements which, to the extent
they are not statements of historical or present fact, constitute
"forward-looking  statements" under the  securities  laws.   From
time to time, oral or written forward-looking statements may also
be  included  in other materials released to the  public.   These
forward-looking  statements are intended to provide  management's
current  expectations  or  plans for  the  future  operating  and
financial  performance  of  the  Company,  based  on  assumptions
currently  believed to be valid.  Forward-looking statements  can
be  identified  by the use of words such as "believe,"  "expect,"
"plans,"    "strategy,"   "prospects,"   "estimate,"   "project,"
"anticipate,"  and other words of similar meaning  in  connection
with  a  discussion of future operating or financial performance.
These include, among others, statements relating to:

-    future   earnings  and  other  measurements   of   financial
     performance,
-    future cash flow and uses of cash,
-    the  effect  of  economic downturns or growth in  particular
     regions,
-    the effect of changes in the level of activity in particular
     industries or markets,
-    the scope or nature of acquisition activity,
-    prospective   product   developments   and   new    business
     opportunities,
-    cost reduction efforts,
-    the outcome of contingencies, and
-    the transition to the use of the euro as a currency.

All  forward-looking statements involve risks  and  uncertainties
that  may  cause actual results to differ materially  from  those
expressed  or  implied  in the forward-looking  statements.   For
additional information identifying factors that may cause  actual
results  to  vary  materially from those stated in  the  forward-
looking  statements,  see the Company's reports  on  Forms  10-K,
10-Q,  and  8-K filed with the Securities and Exchange Commission
from time to time.  The Company's Annual Report on Form 10-K  for
fiscal  year  2000  includes important  information  as  to  risk
factors  in  the "Business" section under the headings "Operating
Segments"  and  "Other  Matters  Relating  to  the  Corporation's
Business as a Whole."

<PAGE 18>

ITEM 3.   QUANTITATIVE AND QUALITATIVE DISCLOSURES
          ABOUT MARKET RISK

No  material  changes  have  occurred  in  the  quantitative  and
qualitative  market risk disclosures for the Company  from  those
presented  in  the Company's Annual Report on Form 10-K  for  the
year ended April 30, 2000.

<PAGE 19>

                   PART II - OTHER INFORMATION

ITEM 5.   OTHER INFORMATION

On  August 31, 2000, the Company issued a press release reporting
that  its Board of Directors had authorized the Company to pursue
strategic   alternatives  for  its  Ophthalmic  Lens   Processing
operating  segment,  including the potential divestiture  of  the
segment.   The Company also indicated it had no plans  to  divest
any of its other businesses.

On  August 31, 2000, the Company also reported the appointment of
F.  David  Jones  as President of the Sign Making  and  Specialty
Graphics  operating segment and Senior Vice President  of  Gerber
Scientific, Inc. Jones was previously Group Managing Director  of
the Company's Spandex PLC unit.

On October 26, 2000, the Company issued a press release reporting
the  appointment of Marc T. Giles as President of the Apparel and
Flexible  Materials operating segment and a Senior Vice President
of  Gerber  Scientific,  Inc.   Giles  was  previously  with  FMC
Corporation as Division Manager, Food Systems and Handling.

Also  announced  in the Apparel and Flexible Materials  operating
segment was the appointment of Bernard J. Demko as Executive Vice
President  and  Chief Operating Officer in a press release  dated
September  29,  2000.  Demko was previously  Vice  President  and
Corporate Controller at Gerber Scientific, Inc.

<PAGE 20>



                   PART II - OTHER INFORMATION


ITEM 6.  EXHIBITS AND REPORTS ON FORM 8-K

(a)  Exhibits

     (10.1)*     Employment  Agreement dated as of October  20,
                 2000  between the Company, Gerber  Technology,
                 and Marc T. Giles.

     (10.2)*     Letter Agreement dated as of November 6,  2000
                 between  the  Company, Gerber Technology,  and
                 Fredric K. Rosen.

     (15)*       Letter  regarding unaudited interim  financial
                 information.

     (27)*       Financial data schedule.

     (99)*       Supplemental Segment Information


(b)  Reports on Form 8-K

     No  Form  8-K  was filed during the quarter for  which  this
     report is filed.



*Filed herewith.

<PAGE 21>

                            SIGNATURE


Pursuant  to the requirements of the Securities Exchange  Act  of
1934, the Registrant has duly caused this report to be signed  on
its behalf by the undersigned, thereunto duly authorized.




                               GERBER SCIENTIFIC, INC.
                              ------------------------
                                    (Registrant)




Date:   December 14, 2000   By:  / s / Gary K. Bennett
        ------------------       --------------------------------
                                 Gary K. Bennett
                                 Senior Vice President, Finance
                                 (Principal Financial and
                                 Accounting Officer)

<PAGE 22>

                          EXHIBIT INDEX





  Exhibit
   Index                                                     Page
  Number                                                     ----
 --------
  (10.1)*      Employment Agreement dated as of October 20,
               2000 between the Company, Gerber Technology,
               and Marc T. Giles.

  (10.2)*      Letter  Agreement dated as  of  November  6,
               2000 between the Company, Gerber Technology,
               and Fredric K. Rosen.

   (15)*       Letter regarding unaudited interim financial
               information.

   (27)*       Financial data schedule.

   (99)*       Supplemental Segment Information






*Filed herewith.